These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2189488)

  • 1. Ras activation in myelodysplastic syndromes: clinical and molecular study of the chronic phase of the disease.
    Melani C; Haliassos A; Chomel JC; Miglino M; Ferraris AM; Gaetani GF; Kaplan JC; Kitzis A
    Br J Haematol; 1990 Apr; 74(4):408-13. PubMed ID: 2189488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes.
    Lyons J; Janssen JW; Bartram C; Layton M; Mufti GJ
    Blood; 1988 Jun; 71(6):1707-12. PubMed ID: 3285909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible co-existence of RAS activation and monosomy 7 in the leukaemic transformation of myelodysplastic syndromes.
    Stephenson J; Lizhen H; Mufti GJ
    Leuk Res; 1995 Oct; 19(10):741-8. PubMed ID: 7500652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
    Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
    Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
    Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
    Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.
    Hirai H; Kobayashi Y; Mano H; Hagiwara K; Maru Y; Omine M; Mizoguchi H; Nishida J; Takaku F
    Nature; 1987 Jun 4-10; 327(6121):430-2. PubMed ID: 3295562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal analysis of point mutations of the N-ras proto-oncogene in patients with myelodysplasia using archived blood smears.
    van Kamp H; de Pijper C; Verlaan-de Vries M; Bos JL; Leeksma CH; Kerkhofs H; Willemze R; Fibbe WE; Landegent JE
    Blood; 1992 Mar; 79(5):1266-70. PubMed ID: 1536950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of ras gene activation in myeloid leukemic cells.
    Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP
    Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia.
    Vasioukhin V; Anker P; Maurice P; Lyautey J; Lederrey C; Stroun M
    Br J Haematol; 1994 Apr; 86(4):774-9. PubMed ID: 7918071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of N-RAS exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing.
    Bar-Eli M; Ahuja H; Gonzalez-Cadavid N; Foti A; Cline MJ
    Blood; 1989 Jan; 73(1):281-3. PubMed ID: 2642713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of N-ras oncogene in myelodysplastic syndromes and leukemias detected by polymerase chain reaction.
    Mano H; Ishikawa F; Hirai H; Takaku F
    Jpn J Cancer Res; 1989 Feb; 80(2):102-6. PubMed ID: 2498243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oncogenes in human leukemia].
    Takaku F
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):617-23. PubMed ID: 2650633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.
    Janssen JW; Steenvoorden AC; Lyons J; Anger B; Böhlke JU; Bos JL; Seliger H; Bartram CR
    Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9228-32. PubMed ID: 3122217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation.
    Padua RA; Carter G; Hughes D; Gow J; Farr C; Oscier D; McCormick F; Jacobs A
    Leukemia; 1988 Aug; 2(8):503-10. PubMed ID: 3166076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the Ki-ras oncogene in endometrial carcinoma.
    Ignar-Trowbridge D; Risinger JI; Dent GA; Kohler M; Berchuck A; McLachlan JA; Boyd J
    Am J Obstet Gynecol; 1992 Jul; 167(1):227-32. PubMed ID: 1442931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes.
    Neubauer A; Greenberg P; Negrin R; Ginzton N; Liu E
    Leukemia; 1994 Apr; 8(4):638-41. PubMed ID: 7512175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-fms point mutations in acute myeloid leukemia: fact or fiction?
    Springall F; O'Mara S; Shounan Y; Todd A; Ford D; Iland H
    Leukemia; 1993 Jul; 7(7):978-85. PubMed ID: 8321048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of RNA and DNA specific for erb B in unbalanced 1;7 chromosomal translocation associated with myelodysplastic syndrome.
    Woloschak GE; Dewald GW; Bahn RS; Kyle RA; Greipp PR; Ash RC
    J Cell Biochem; 1986; 32(1):23-34. PubMed ID: 3464613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-ras mutation and karyotypic evolution are closely associated with leukemic transformation in myelodysplastic syndrome.
    Horiike S; Misawa S; Nakai H; Kaneko H; Yokota S; Taniwaki M; Yamane Y; Inazawa J; Abe T; Kashima K
    Leukemia; 1994 Aug; 8(8):1331-6. PubMed ID: 8057669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activation of ras oncogene in myelodysplastic syndrome and acute myelogenous leukemia].
    Hirai H; Hirano N; Yazaki Y
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1090-7. PubMed ID: 2053767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.